Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

("Osaic"), one of the nation's largest providers of wealth management solutions, today announced that Ever Wealth, an Auburn, Indiana-based advisory firm with more than $170 million in client assets, ...

Fintel reports that on March 19, 2025, Ladenburg Thalmann downgraded their outlook for Public Service Enterprise Group ...

Fintel reports that on March 17, 2025, Ladenburg Thalmann initiated coverage of Veritone (NasdaqGM:VERI) with a Buy ...

A Commerce Department report showed retail sales rebounded 0.2% in February, after a revised 1.2% decline in January. However ...

Ladenburg lowered the firm’s price target on Ardelyx (ARDX) to $11 from $13.50 and keeps a Buy rating on the shares following a transfer of analyst coverage. See what stocks are receiving Strong ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corporation's fourth quarter of 2024 earnings conference call. My name is Pia, and I will be your conference operator today.

Long-term stability indicates a strong investment culture. On average, Ladenburg Thalmann's longest-tenured strategy managers have 15 years of tenure. This level of experience should give ...

The last upgrade for Compass Therapeutics Inc happened on September 16, 2024 when Ladenburg Thalmann raised their price target to $5. Ladenburg Thalmann previously had a neutral for Compass ...